Q. Huang

A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia

Li-Jun Jiang, M. Cantillon, Wei Chen, 2020, Alzheimer's Research & Therapy.

A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia

Li-Jun Jiang, M. Cantillon, Wei Chen, 2021, Alzheimer's research & therapy.

A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia

Wei Chen, Kewei Chen, Y. Guan, 2020, Alzheimer's research & therapy.

Chinese Preclinical Alzheimer’s Disease Study (C-PAS): Design and Challenge from PET Acceptance

Y. Guan, L. Huang, Qihao Guo, 2023, The Journal of Prevention of Alzheimer's Disease.

Discriminant analysis in the study of Alzheimer’s disease using feature extractions and support vector machines in positron emission tomography with 18F-FDG

S. Su, Q. Huang, Ke-Wei Chen, 2014, Journal of Shanghai Jiaotong University (Science).

Effects of Memantine on Clinical Ratings, Fluorodeoxyglucose Positron Emission Tomography Measurements, and Cerebrospinal Fluid Assays in Patients With Moderate to Severe Alzheimer Dementia: A 24-Week, Randomized, Clinical Trial

E. Reiman, Kewei Chen, Chunbo Li, 2013, Journal of clinical psychopharmacology.